亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Taurine Boosts Intracellular Delivery of Functional Molecules

技術優勢
·      Covalent conjugation of taurine is abroadlyapplicable approach to boost the intracellulardelivery of bioactivemolecular and therapeuticagents·      The taurine motif ensurestransportation and thesubsequent intracellular nanofibrils formationunderenzymatic catalysis can efficiently reducethe molecular diffusion outside ofcells, providing anew mechanism that eradicates drug resistance.·      This method avoids the possibilityof immuneresponse and toxicity caused by CPPs·      The natural and non-proteinogenicamino acid,taurine, is widely available, accessible, and itsmolecularmodification facile
技術應用
·      As an effective method to delivertherapeutic agents, genes, proteins, and siRNA through otherwise imperviouscellular membranes into targeted cells·      A fluorophore may also be conjugated toallowfor intracellular imaging studies
詳細技術說明
Taurine modified D-peptide conjugates significantly enhances cellular uptake of therapeutic molecules for disease diagnosis and treatment.
*Abstract

Internalization of functional moleculesis the basis for intracellular delivery of therapeutic agents for the treatmentand diagnosis of diseases. Unfortunately, the delivery of biologically activemolecules into cells is prevented by the non-permeable plasma cell membrane.Cell penetrating proteins (CPPs) are traditionally used to facilitate thecellular uptake of various cargo, but CPPs are limited by their susceptibilityto metabolic degradation, dependency on cell lines, and poor cellularcompatibility.

The present invention relieson the covalent conjugation of taurine to a D-peptidic hydrogel precursor toovercome the limitations of non-permeable cell membranes and CPPs.Taurine-promoted cellular uptake boosts intracellular delivery by 10X andeliminates immune response, poor stability, and toxicity caused by CPPs. Thisis novel strategy for targeted intracellular enzyme instructed self-assembly ofhydrogels for cancer treatment and may serve as an effective method to delivertherapeutic agents, genes, proteins, and siRNA through otherwise imperviouscellular membranes into targeted cells.

*IP Issue Date
None
*IP Type
Provisional
國家
United States
申請號碼
62/121,237
國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備